EyeGate's EGP-437 Matches the Standard-of-Care's Response Rate in Phase III ... PipelineReview.com (press release) Our team has invested several years into developing this delivery platform and continues to advance our understanding of its versatility beyond the use of corticosteroids, such as EGP-437, including the delivery of proteins to the back of the eye ... Study: Iontophoretic corticosteroid treatment matches standard-of-care ... |
